T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.11B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.59B |
| 3 |
EQT Corp
EQT
|
+$1.31B |
| 4 |
Colgate-Palmolive
CL
|
+$1.08B |
| 5 |
Adobe
ADBE
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.92B |
| 2 |
UnitedHealth
UNH
|
+$1.78B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.55B |
| 4 |
Ross Stores
ROST
|
+$1.54B |
| 5 |
ASML
ASML
|
+$1.49B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.61% |
| 2 | Healthcare | 16.91% |
| 3 | Consumer Discretionary | 11.05% |
| 4 | Financials | 10.6% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Limbach Holdings
LMB
$527M
| $242K | ﹤0.01% |
+9,770
| New | +$197K |
|
2452
NWPX Infrastructure Inc
NWPX
$1.11B
| $242K | ﹤0.01% |
7,977
| – | – |
|
2453
Orion
OEC
$360M
| $242K | ﹤0.01% |
11,362
-305
| -3% | -$7.35K |
|
2454
Schneider National
SNDR
$6.37B
| $241K | ﹤0.01% |
8,378
-22
| -0.3% | -$586 |
|
2455
DHT Holdings
DHT
$3.09B
| $240K | ﹤0.01% |
28,080
+1,680
| +6% | +$14.7K |
|
2456
Avita Medical
RCEL
$248M
| $240K | ﹤0.01% |
14,099
+3,499
| +33% | +$51.3K |
|
2457
First Internet Bancorp
INBK
$256M
| $239K | ﹤0.01% |
16,028
+3,948
| +33% | +$54.8K |
|
2458
KVH Industries
KVHI
$143M
| $239K | ﹤0.01% |
26,078
+8,715
| +50% | +$87.8K |
|
2459
Atomera
ATOM
$212M
| $237K | ﹤0.01% |
26,910
-6,219
| -19% | -$49.1K |
|
2460
Reynolds Consumer Products
REYN
$5.55B
| $235K | ﹤0.01% |
8,310
-120
| -1% | -$3.34K |
|
2461
Treace Medical Concepts
TMCI
$293M
| $235K | ﹤0.01% |
+9,157
| New | +$236K |
|
|
DCH
2462
Dauch Corp
DCH
$1.6B
| $234K | ﹤0.01% |
28,254
+2,172
| +8% | +$16.1K |
|
2463
Blink Charging
BLNK
$87.1M
| $234K | ﹤0.01% |
38,994
+7,345
| +23% | +$50.9K |
|
2464
Washington Trust Bancorp
WASH
$767M
| $233K | ﹤0.01% |
8,690
+255
| +3% | +$7.13K |
|
|
CANO
2465
DELISTED
Cano Health, Inc.
CANO
| $232K | ﹤0.01% |
1,669
+402
| +32% | +$51.6K |
|
2466
NN Inc
NNBR
$298M
| $231K | ﹤0.01% |
96,320
+11,400
| +13% | +$17.3K |
|
|
CMAX
2467
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $231K | ﹤0.01% |
2,470
+181
| +8% | +$15.9K |
|
2468
XPeng
XPEV
$11.3B
| $229K | ﹤0.01% |
17,000
+3,800
| +29% | +$37.4K |
|
2469
American Superconductor
AMSC
$1.53B
| $228K | ﹤0.01% |
36,400
-3,700
| -9% | -$18K |
|
|
TWOU
2470
DELISTED
2U Inc
TWOU
| $228K | ﹤0.01% |
1,885
-347
| -16% | -$46.1K |
|
2471
Kodak
KODK
$978M
| $227K | ﹤0.01% |
48,942
+590
| +1% | +$2.49K |
|
|
STEL
2472
DELISTED
Stellar Bancorp
STEL
| $227K | ﹤0.01% |
9,914
+1,360
| +16% | +$31.7K |
|
|
LOVE
2473
LoveSac
LOVE
$258M
| $226K | ﹤0.01% |
8,353
+82
| +1% | +$2.09K |
|
|
ALPN
2474
DELISTED
Alpine Immune Sciences Inc
ALPN
| $224K | ﹤0.01% |
21,740
+2,115
| +11% | +$19.1K |
|
2475
Amneal Pharmaceuticals
AMRX
$6.02B
| $223K | ﹤0.01% |
71,808
+51,989
| +262% | +$111K |
|
Similar funds
T. Rowe Price Associates's Q2 2023 Portfolio in Review
As of Q2 2023, T. Rowe Price Associates held 3,044 positions worth $718B, up 7.4% from $668B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2023 filing shows 123 new, 1,636 increased, 968 reduced and 150 closed positions. Its largest new stake was Kenvue: 26,317,608 shares worth $695M. The largest sale was Microsoft, an estimated $1.92B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2023 buy was Kenvue: 26,317,608 shares worth $695M.
- T. Rowe Price Associates added most to Amazon in Q2 2023, an estimated $3.11B increase.
- T. Rowe Price Associates's biggest Q2 2023 reduction was Microsoft, cutting an estimated $1.92B.
- T. Rowe Price Associates fully exited Canadian Natural Resources in Q2 2023, selling an estimated $112M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $718B portfolio in Q2 2023.
- T. Rowe Price Associates opened 123 new positions and closed 150 in Q2 2023.
- T. Rowe Price Associates's portfolio value rose 7.4% quarter-over-quarter to $718B.
Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.